SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 116 filers reported holding SUTRO BIOPHARMA INC in Q1 2023. The put-call ratio across all filers is 2.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,680,816 | -4.1% | 2,501,676 | +28.5% | 0.10% | -16.5% |
| Q2 2023 | $9,051,969 | +71.0% | 1,946,660 | +69.9% | 0.12% | +65.8% |
| Q1 2023 | $5,293,531 | -59.2% | 1,145,786 | -28.6% | 0.07% | -64.0% |
| Q4 2022 | $12,962,170 | +86.1% | 1,604,229 | -36.0% | 0.20% | +157.0% |
| Q3 2022 | $6,966,960 | +84.4% | 2,508,210 | +245.9% | 0.08% | +5.3% |
| Q2 2022 | $3,778,000 | +37.4% | 725,081 | +292.4% | 0.08% | +275.0% |
| Q4 2021 | $2,749,000 | -10.7% | 184,765 | +13.3% | 0.02% | -25.9% |
| Q3 2021 | $3,079,000 | +58.8% | 163,007 | +56.3% | 0.03% | +50.0% |
| Q2 2021 | $1,939,000 | -81.9% | 104,320 | -77.9% | 0.02% | -85.1% |
| Q1 2021 | $10,728,000 | +51.7% | 471,332 | +44.7% | 0.12% | +95.2% |
| Q4 2020 | $7,072,000 | +242.1% | 325,765 | +58.4% | 0.06% | +51.2% |
| Q3 2020 | $2,067,000 | – | 205,698 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $39,611,000 | 19.08% |
| Samsara BioCapital, LLC | 1,675,579 | $36,377,000 | 3.66% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 185,000 | $4,016,000 | 2.33% |
| Affinity Asset Advisors, LLC | 200,000 | $4,342,000 | 2.30% |
| Altium Capital Management LP | 276,719 | $6,008,000 | 2.24% |
| FRAZIER MANAGEMENT LLC | 1,001,421 | $21,741,000 | 1.67% |
| BVF INC/IL | 1,854,162 | $40,254,000 | 1.58% |
| Asymmetry Capital Management, L.P. | 157,583 | $3,421,000 | 1.56% |
| Parkman Healthcare Partners LLC | 266,645 | $5,789,000 | 1.48% |
| AJU IB Investment Co., Ltd. | 175,000 | $3,799,000 | 1.44% |